Item 9 Labs (OTC:INLB) Stock Price Up 23.5%
Item 9 Labs (OTC:INLB) Stock Price Up 23.5%
Shares of Item 9 Labs Corp. (OTC:INLB – Get Rating) were up 23.5% during trading on Friday . The stock traded as high as $0.21 and last traded at $0.21. Approximately 15,915 shares traded hands during mid-day trading, a decline of 14% from the average daily volume of 18,450 shares. The stock had previously closed at $0.17.
Item 9 Labs Price Performance
The company has a market capitalization of $20.79 million, a P/E ratio of -0.84 and a beta of 0.55. The business's 50-day moving average is $0.26 and its two-hundred day moving average is $0.45. The company has a quick ratio of 0.04, a current ratio of 0.14 and a debt-to-equity ratio of 0.02.
About Item 9 Labs
(Get Rating)
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
Featured Articles
- Get a free copy of the StockNews.com research report on Item 9 Labs (INLB)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Item 9 Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Item 9 Labs and related companies with MarketBeat.com's FREE daily email newsletter.
Item 9 Labs Corp.(场外交易代码:INLB-GET评级)的股价在周五的交易中上涨了23.5%。该股一度涨至0.21美元,最后报0.21美元。午盘交易中,约有15,915股股票成交,较18,450股的日均成交量下降了14%。该股此前收盘价为0.17美元。
第9项实验室性价比
该公司市值为2,079万美元,市盈率为-0.84,贝塔系数为0.55。该业务的50日移动均线切入位在0.26美元,200日移动均线切入位在0.45美元。该公司的速动比率为0.04,流动比率为0.14,债务权益比率为0.02。
关于第9项实验
(获取评级)
第九项实验室公司在美国是一家垂直整合的大麻运营商和药房特许经营商。该公司生产各种类别的大麻和大麻相关产品,如鲜花、浓缩物、蒸馏液和五金制品。它通过获得许可的药房向亚利桑那州的消费者提供大麻和大麻衍生产品和技术。
专题文章
- 免费获取StockNews.com关于第9项实验室的研究报告(INLB)
- MarketBeat:回顾中的一周01/02-01/06
- 为什么CrowdStrike的股价举步维艰?
- 2023年四只被低估的医疗保健股票
- WWE股票:文斯·麦克马洪想要重返节目
- NVIDIA正在触底,但现在还不能买入
每天接收第九项实验的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收关于Item 9实验室和相关公司的最新新闻和分析师评级的每日简要摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧